Japan's health ministry panel on Thursday approved the commercialization of two regenerative medicine products prepared from iPS cell ...

You’re relaxing on the sofa when suddenly your eyelid starts twitching. Or perhaps it’s a muscle in your arm, your leg, or your foot that begins to spasm – sometimes for a few seconds, sometimes for ...

Newsweek and Statista are evaluating Japan's Best Physical Rehabilitation Facilities for 2026.

Japan Approves Worlds First iPS Therapies for Parkinsons, Heart Failure Conditional approval granted for Sumitomo Pharmas ...

Legions of fans from around the world have been cheering on Punch, a 7-month-old macaque who had been struggling to socialize ...

Weight loss is common in Parkinson’s disease, but its biological basis has been unclear. Researchers at Fujita Health University show that this loss reflects reduced body fat, not muscle, along with a ...

Drugs made with iPS, or induced pluripotent stem cells, will be used to treat patients with severe heart failure and Parkinson’s disease.

The Taiwan Creative Content Agency ( TAICCA) is spearheading the territory’s EFM activities with its Taiwan Pavilion and ...

An expert panel is set to discuss whether Japan's health ministry should approve two products using iPS cells. The treatments ...

Muscle car history tends to orbit the same legends, yet one corporate workaround quietly turned a handsome pony car into a ...

Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 13 hot stocks to buy with the highest upside potential. As of February 13, ...